Metabolic syndrome is a constellation of major risk factors for cardiovascular disease. In affected individuals with this syndrome, the independent contribution of low high-density lipoprotein-cholesterol and increased triglyceride levels to the development of atherosclerosis remains to be clarified. We assessed the relationship between these 2 parameters and several surrogate markers for atherosclerosis. One hundred and twenty overweight cases, defined as having high-density lipoprotein-cholesterol (<or=25 age- and gender-specific percentile in general population) and high triglyceride values (>or=75 percentile) were compared with 120 discordant overweight controls defined on lipid values (high-density lipoprotein-cholesterol >or=...
Background and aims We aimed to identify clusters of metabolic syndrome (MetS) components, risky for...
Background - Few reports are available on the contribution of general and abdominal obesity to the p...
SummaryObjectivesTo evaluate the role of non-traditional biochemical markers, and carotid and femora...
Metabolic syndrome is a constellation of major risk factors for cardiovascular disease. In affected ...
(HDL)–cholesterol of less than 1.04 mmol/L in men and 1.29 mmol/L in women; blood pressure of at lea...
Abstract Background: Excessive weight is a cardiovascular risk factor since it generates a chronic ...
BACKGROUND: The development of metabolic syndrome (MS) augments risk for atherosclerotic cardiovascu...
Current algorithms for assessing risk of atherosclerotic cardiovascular disease (ASCVD) and, in part...
Introduction: The prevalence of cardiovascular disease (CVD) and its associated costs continue to in...
A number of food micronutrients are reported to influence markers of cardio-metabolic health. There ...
The metabolic dysfunctions anddiseases clustered under the Metabolic Syndrome (MS)definition are all...
Low plasma HDL cholesterol (HDL-c) has been recognized as a biomarker of cardiovascular disease (CVD...
Background- Carotid intima-media thickness (CIMT), a subclinical measure of atherosclerosis, is asso...
Background and aims We aimed to identify clusters of metabolic syndrome (MetS) components, risky for...
OBJECTIVE: Body fatness and fat distribution are widely accepted as coronary heart disease risk fac...
Background and aims We aimed to identify clusters of metabolic syndrome (MetS) components, risky for...
Background - Few reports are available on the contribution of general and abdominal obesity to the p...
SummaryObjectivesTo evaluate the role of non-traditional biochemical markers, and carotid and femora...
Metabolic syndrome is a constellation of major risk factors for cardiovascular disease. In affected ...
(HDL)–cholesterol of less than 1.04 mmol/L in men and 1.29 mmol/L in women; blood pressure of at lea...
Abstract Background: Excessive weight is a cardiovascular risk factor since it generates a chronic ...
BACKGROUND: The development of metabolic syndrome (MS) augments risk for atherosclerotic cardiovascu...
Current algorithms for assessing risk of atherosclerotic cardiovascular disease (ASCVD) and, in part...
Introduction: The prevalence of cardiovascular disease (CVD) and its associated costs continue to in...
A number of food micronutrients are reported to influence markers of cardio-metabolic health. There ...
The metabolic dysfunctions anddiseases clustered under the Metabolic Syndrome (MS)definition are all...
Low plasma HDL cholesterol (HDL-c) has been recognized as a biomarker of cardiovascular disease (CVD...
Background- Carotid intima-media thickness (CIMT), a subclinical measure of atherosclerosis, is asso...
Background and aims We aimed to identify clusters of metabolic syndrome (MetS) components, risky for...
OBJECTIVE: Body fatness and fat distribution are widely accepted as coronary heart disease risk fac...
Background and aims We aimed to identify clusters of metabolic syndrome (MetS) components, risky for...
Background - Few reports are available on the contribution of general and abdominal obesity to the p...
SummaryObjectivesTo evaluate the role of non-traditional biochemical markers, and carotid and femora...